# Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors

> **NCT06227962** · — · ENROLLING_BY_INVITATION · sponsor: **Amsterdam University Medical Center** · enrollment: 240 (estimated)

## Conditions studied

- Retinoblastoma
- Neurocognitive Dysfunction
- Health-Related Behavior

## Interventions

- **DIAGNOSTIC_TEST:** Neuropsychological assesment
- **DIAGNOSTIC_TEST:** Psychosocial functioning and quality of life (questionnaires)
- **DIAGNOSTIC_TEST:** Parental psychosocial functioning (questionnaires)

## Key facts

- **NCT ID:** NCT06227962
- **Lead sponsor:** Amsterdam University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-10-26
- **Primary completion:** 2026-10-30
- **Final completion:** 2028-03-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06227962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06227962, "Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06227962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*